We intend to execute a $125 million Accelerated Share Repurchase imminently, which reflects the Company's balance sheet strength and free cash flow generation NEW YORK, March 11, 2026--(BUSINESS WIRE) ...
Good afternoon, everyone, and thank you for participating in today's conference call to discuss Concrete Pumping Holdings financial results for the first quarter ended January 31, 2026. Joining us ...
Rentokil Initial plc (NYSE:RTO) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Hello, and welcome to the Rentokil Full Year Results 2025. My name is Carla, and I will be coordinating your ...
Vermilion Energy Inc. ( VET:CA) Q4 2025 Earnings Call March 5, 2026 10:00 AM EST Good morning, ladies and gentlemen, and welcome to the Vermilion Q4 2025 Conference Call. [Operator Instructions] This ...
Vermilion Energy Inc. (NYSE:VET) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good morning, ladies and gentlemen, and welcome to the Vermilion Q4 2025 Conference Call. [Operator ...
Conference call today at 8:30 a.m. ET ORLANDO, FLORIDA / ACCESS Newswire / March 9, 2026 / Unusual Machines (NYSE ...
The U.S. International Trade Commission’s ruling favoring GoPro against Insta360 strengthened intellectual property protections and was cited as validation of GoPro's innovation-centric business model ...
(NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed ...
SandRidge Energy, Inc. (the "Company" or "SandRidge") (NYSE: SD) today announced financial and operational results for ...
Conference call today at 8:30 a.m. ET ORLANDO, FLORIDA / ACCESS Newswire / March 9, 2026 / Unusual Machines (NYSE American:UMAC) ("Unusual Machines" or the "Company"), a leading provider of NDAA-compl ...
When Andy Searls moved to Summit County in 2005, she was in her late 60s and quickly became involved in conversations about ...
Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data ...